Histrelin Acetate Patent Expiration

Histrelin Acetate is Used for treating central precocious puberty in children. It was first introduced by Shire Development Inc in its drug Supprelin on Dec 24, 1991. Other drugs containing Histrelin Acetate are Vantas, Supprelin La. 2 different companies have introduced drugs containing Histrelin Acetate.

Histrelin Acetate Patents

Given below is the list of patents protecting Histrelin Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Supprelin La US8062652 Compositions and methods for treating precocious puberty Jun 16, 2026 Endo Operations

Coming Soon

Patent Strength Analyzer

Will this be useful for you?


Thank you for your response 🥳